Clinical Trial Update: Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in Children [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating radiotherapy combined with apatinib mesylate for childhood rhabdomyosarcoma; efficacy and safety data not yet available in the provid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Drugs mentioned

• Apatinib Mesylate (apatinib)

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Childhood Rhabdomyosarcoma | Phase 1, Phase 2 | Status: UNKNOWN